Evoke by Firefly Neuro

Evoke Neuroscience, founded in 2009, specializes in computational EEG technology to enhance brain health assessments. Their mission is to make brain health scans routine and accessible, aiming to improve early diagnosis and treatment of cognitive impairments. The flagship product, the evoke® Brain Health System (eVox® System), integrates electrophysiological sensors and advanced software to perform in-office brain health scans. This system assists healthcare providers, including general practitioners and neurologists, in detecting cognitive impairment early, potentially delaying disease progression. The company has achieved significant milestones, including FDA 510(k) clearance and ISO certification. They have performed over 100,000 brain health assessments, collecting more than 2 billion data points. Evoke Neuroscience is exploring expansion into sports and consumer neurotechnology markets and is investigating the integration of transcranial direct current stimulation (tDCS) technology with their systems to enhance treatment for neurological disorders. With offices in New York City and Jacksonville, NC, Evoke Neuroscience aims to improve outcomes for those affected by cognitive disorders.

• Employees 11
• Founded 2009
• Annual Revenue $4500000